Exercise-Induced Metabolic Compensation; a Physiological Adaptive Response to Exercise Training

February 21, 2024 updated by: Gepner Yftach, Tel Aviv University
The primary aim of this proposal is to identify changes in the volume of highly metabolic organs (liver, kidneys, and brain) that occur as a physiological adaptation to exercise training and lower the resting energy expenditure. Secondary aims are to identify changes in the metabolic efficiency of muscle in low levels of physical activity and evaluate the effects on components of total daily energy expenditure including the sleeping metabolic rate (SMR) and diet induced thermogenesis (DIT).

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Using a clinical trial type protocol, 16 overweight (body mass index: 25-30 kg/m2) men (n=8) and women (n=8) aged 21 to 45 years will exercise for 3 months in a moderate intensity regimen of 20 kcal/week/kg body weight that reflects current recommendations for weight management. The volume of various organs will be measured pre- and post-exercise intervention using magnetic resonance imaging (MRI). A cycling ergometer with a varied workload will be used to assess muscle metabolic efficiency. Changes in overnight SMR and 4 hours post breakfast DIT will be evaluated by whole human room indirect calorimetry ("metabolic chamber"). In addition, free-living Total Energy Expenditure (TEE) will be measured for ten days pre- and post-intervention by doubly labeled water.

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Other
      • Tel Aviv, Other, Israel, 6997801
        • Tel Aviv University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Overweight [body mass index (BMI) 25-30

Exclusion Criteria:

  • Participation in another exercise or weight loss program in the last 6 months
  • Non-stable weight (>±5%) over the past 6 months
  • Current regular exercise > 1 hour per week
  • Smoking within the past 6 months
  • Being post-menopausal, breastfeeding, pregnancy, or having been pregnant within the past 6 months
  • Previous bariatric surgery
  • Cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina)
  • Musculoskeletal or neuromuscular impairments that preclude exercise training
  • Having other health issues include cancer, diabetes, thyroid disease, hypertension, chronic renal failure, cognitive impairments
  • Use of drugs that potentially impact body metabolism.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Exercise in moderate intensity tailored individually to 20 kcal/kg/week (range 1500-2000 kcal/week) with a free choice to exercise at home/gym on a treadmill or outdoors.

The first phase of the study will comprise two weeks of control phase when participants will not engage in any exercise training but will be monitored for total daily energy expenditure and its components (REE, SMR, and DIT) and assessed volume of metabolic organs and skeletal muscle efficiency.

Next, participants will start the active phase. In the first two weeks, participants will perform 150 - 200 min/week of a moderate intensity exercise so that they can adapt to the new regime and avoid injury. All exercise training will be monitored using heart rate sensor (HR) to track exercise adherence and HR range goals. Changes in daily non-exercise physical activity and sedentary behavior will be assessed for 10 days pre- and post-intervention by a tri-axial accelerometer. All study participants will be instructed to consume their habitual diet and to maintain the same caloric intake.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To examine long-term changes in the volume of highly metabolic organs (brain, liver, and kidneys) as an adaptive metabolic response to exercise training
Time Frame: Pre- and post 12 weeks of exercise intervention
The volume of various organs will be measured using magnetic resonance imaging (MRI).
Pre- and post 12 weeks of exercise intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate the changes in skeletal muscle metabolic efficiency during non- exercise physical activity as an adaptive response to long-term exercise training
Time Frame: Pre- and post 12 weeks of exercise intervention
A cycling ergometer with a varied workload will be used to assess muscle metabolic efficiency
Pre- and post 12 weeks of exercise intervention
To determine the effect of long-term exercise training on changes in sleeping metabolic rate as an adaptive response .
Time Frame: Pre- and post 12 weeks of exercise intervention
Changes in overnight sleeping metabolic rate will be evaluated by whole human room indirect calorimetry ("metabolic chamber")
Pre- and post 12 weeks of exercise intervention
To assess the effect of long-term exercise training on changes in diet induced thermogenesis as an adaptive response.
Time Frame: Pre- and post 12 weeks of exercise intervention
Changes in diet induced thermogenesis will be evaluated 4 hours post breakfast by whole human room indirect calorimetry ("metabolic chamber")
Pre- and post 12 weeks of exercise intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yftach Gepner, PhD, Tel Aviv University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2021

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

November 1, 2024

Study Registration Dates

First Submitted

June 29, 2020

First Submitted That Met QC Criteria

July 5, 2020

First Posted (Actual)

July 7, 2020

Study Record Updates

Last Update Posted (Actual)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 21, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Metabolism

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Training

Clinical Trials on Exercise training

Subscribe